41 KiB
41 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 4 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 5 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 6 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 7 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 8 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Total Bilirubin | 12 | 3 - 21 | umol/L | ||||||||||
| 9 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.3 | 0 - 6.2 | umol/L | ||||||||||
| 10 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Alkaline Phosphatase | 53 | 35 - 104 | U/L | ||||||||||
| 11 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | ALT (SGPT) | 20 | 4 - 43 | U/L | ||||||||||
| 12 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||||
| 13 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | GGT | 16 | 4 - 49 | U/L | ||||||||||
| 14 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | LDH | 150 | 53 - 234 | U/L | ||||||||||
| 15 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Urea Nitrogen | 4.0 | 1.4 - 8.6 | mmol/L | ||||||||||
| 16 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 67 | 31 - 101 | umol/L | ||||||||||
| 17 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Serum Glucose | 4.5 | 3.9 - 5.6 | mmol/L | ||||||||||
| 18 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Serum Uric Acid | 184 | 149 - 446 | umol/L | ||||||||||
| 19 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Calcium (EDTA) | 2.55 | 2.07 - 2.64 | mmol/L | ||||||||||
| 20 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Phosphorus | 1.17 | 0.71 - 1.65 | mmol/L | ||||||||||
| 21 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||||
| 22 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Albumin-BCG | 49 | 33 - 49 | g/L | ||||||||||
| 23 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Creatine Kinase | 98 | 26 - 192 | U/L | ||||||||||
| 24 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 25 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||||
| 26 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Serum Bicarbonate | 23.5 | 19.3 - 29.3 | mmol/L | ||||||||||
| 27 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||||
| 28 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | CHEMISTRY PANEL | Magnesium | 0.84 | 0.66 - 1.07 | mmol/L | ||||||||||
| 29 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | FECAL COLLECTION D/T | Stool Collection Date | Y | 04-Jun-2026 | |||||||||||
| 30 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:30 | |||||||||||
| 31 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 138 | 116 - 164 | g/L | ||||||||||
| 32 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.34 - 0.48 | |||||||||||
| 33 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||||
| 34 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 35 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 36 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 98 | fL | ||||||||||
| 37 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.37 | 3.8 - 10.7 | GI/L | ||||||||||
| 38 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.46 | 1.96 - 7.23 | GI/L | ||||||||||
| 39 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.53 | 0.91 - 4.28 | GI/L | ||||||||||
| 40 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.25 | 0.12 - 0.92 | GI/L | ||||||||||
| 41 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.10 | 0 - 0.57 | GI/L | ||||||||||
| 42 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||||
| 43 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 70.0 | 40.5 - 75 | % | ||||||||||
| 44 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 24.1 | 15.4 - 48.5 | % | ||||||||||
| 45 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.0 | 2.6 - 10.1 | % | ||||||||||
| 46 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.6 | 0 - 6.8 | % | ||||||||||
| 47 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||||
| 48 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 214 | 140 - 400 | GI/L | ||||||||||
| 49 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | PA1 EEA-2? | Approved to use EEA-2? | |||||||||||||
| 50 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 04-Jun-2026 | |||||||||||
| 51 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 09:50 | |||||||||||
| 52 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 04-Jun-2026 | |||||||||||
| 53 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 11:10 | |||||||||||
| 54 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 04-Jun-2026 | |||||||||||
| 55 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 09:50 | |||||||||||
| 56 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 04-Jun-2026 | |||||||||||
| 57 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 06:30 | |||||||||||
| 58 | CZ100092001 | Female | Induction Week 4 | Jun 4, 2026 9:50 AM | 6227323337 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 59 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 60 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 61 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 62 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 63 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 64 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Total Bilirubin | 17 | 3 - 21 | umol/L | ||||||||||
| 65 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 5.0 | 0 - 6.2 | umol/L | ||||||||||
| 66 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 35 - 104 | U/L | ||||||||||
| 67 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | ALT (SGPT) | 18 | 4 - 43 | U/L | ||||||||||
| 68 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | ||||||||||
| 69 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | GGT | 15 | 4 - 49 | U/L | ||||||||||
| 70 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | LDH | 154 | 53 - 234 | U/L | ||||||||||
| 71 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Urea Nitrogen | 3.4 | 1.4 - 8.6 | mmol/L | ||||||||||
| 72 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 73 | 31 - 101 | umol/L | ||||||||||
| 73 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Serum Glucose | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||||
| 74 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Serum Uric Acid | 196 | 149 - 446 | umol/L | ||||||||||
| 75 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Calcium (EDTA) | 2.47 | 2.07 - 2.64 | mmol/L | ||||||||||
| 76 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Phosphorus | 1.10 | 0.71 - 1.65 | mmol/L | ||||||||||
| 77 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Total Protein | 73 | 61 - 84 | g/L | ||||||||||
| 78 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||||
| 79 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Creatine Kinase | 100 | 26 - 192 | U/L | ||||||||||
| 80 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Serum Sodium | 136 | 132 - 147 | mmol/L | ||||||||||
| 81 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||||
| 82 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Serum Bicarbonate | 22.8 | 19.3 - 29.3 | mmol/L | ||||||||||
| 83 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||||
| 84 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CHEMISTRY PANEL | Magnesium | 0.81 | 0.66 - 1.07 | mmol/L | ||||||||||
| 85 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 86 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 86 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | FECAL COLLECTION D/T | Stool Collection Date | Y | 19-May-2026 | |||||||||||
| 87 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:20 | |||||||||||
| 88 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 137 | 116 - 164 | g/L | ||||||||||
| 89 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.34 - 0.48 | |||||||||||
| 90 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.4 | 4.1 - 5.6 | TI/L | ||||||||||
| 91 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 32 | 26 - 34 | pg | ||||||||||
| 92 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 93 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 98 | fL | ||||||||||
| 94 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.57 | 3.8 - 10.7 | GI/L | ||||||||||
| 95 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.33 | 1.96 - 7.23 | GI/L | ||||||||||
| 96 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.77 | 0.91 - 4.28 | GI/L | ||||||||||
| 97 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||||
| 98 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | 0 - 0.57 | GI/L | ||||||||||
| 99 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||||
| 100 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 65.9 | 40.5 - 75 | % | ||||||||||
| 101 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 26.9 | 15.4 - 48.5 | % | ||||||||||
| 102 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.4 | 2.6 - 10.1 | % | ||||||||||
| 103 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.8 | 0 - 6.8 | % | ||||||||||
| 104 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||||
| 105 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 258 | 140 - 400 | GI/L | ||||||||||
| 106 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 107 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 19-May-2026 | |||||||||||
| 108 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 10:50 | |||||||||||
| 109 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 19-May-2026 | |||||||||||
| 110 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 11:55 | |||||||||||
| 111 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 19-May-2026 | |||||||||||
| 112 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 10:50 | |||||||||||
| 113 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 19-May-2026 | |||||||||||
| 114 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 06:20 | |||||||||||
| 115 | CZ100092001 | Female | Induction Week 2 | May 19, 2026 10:50 AM | 6227323335 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 116 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Total Bilirubin | 12 | 3 - 21 | umol/L | ||||||||||
| 117 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.5 | 0 - 6.2 | umol/L | ||||||||||
| 118 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Alkaline Phosphatase | 55 | 35 - 104 | U/L | ||||||||||
| 119 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | ALT (SGPT) | 15 | 4 - 43 | U/L | ||||||||||
| 120 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | AST (SGOT) | 18 | 8 - 40 | U/L | ||||||||||
| 121 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | GGT | 13 | 4 - 49 | U/L | ||||||||||
| 122 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | LDH | 152 | 53 - 234 | U/L | ||||||||||
| 123 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Urea Nitrogen | 5.1 | 1.4 - 8.6 | mmol/L | ||||||||||
| 124 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 62 | 31 - 101 | umol/L | ||||||||||
| 125 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Serum Glucose | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||||
| 126 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Serum Uric Acid | 178 | 149 - 446 | umol/L | ||||||||||
| 127 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Calcium (EDTA) | 2.44 | 2.07 - 2.64 | mmol/L | ||||||||||
| 128 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Phosphorus | 1.09 | 0.71 - 1.65 | mmol/L | ||||||||||
| 129 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||||
| 130 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||||
| 131 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Creatine Kinase | 87 | 26 - 192 | U/L | ||||||||||
| 132 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | ||||||||||
| 133 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Serum Potassium | 4.6 | 3.5 - 5.2 | mmol/L | ||||||||||
| 134 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Serum Bicarbonate | 21.5 | 19.3 - 29.3 | mmol/L | ||||||||||
| 135 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||||
| 136 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CHEMISTRY PANEL | Magnesium | 0.94 | 0.66 - 1.07 | mmol/L | ||||||||||
| 137 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 105 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 138 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | FECAL COLLECTION D/T | Stool Collection Date | Y | 05-May-2026 | |||||||||||
| 139 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:30 | |||||||||||
| 140 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 140 | 116 - 164 | g/L | ||||||||||
| 141 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.34 - 0.48 | |||||||||||
| 142 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||||
| 143 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 144 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 145 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 98 | fL | ||||||||||
| 146 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.60 | 3.8 - 10.7 | GI/L | ||||||||||
| 147 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.94 | 1.96 - 7.23 | GI/L | ||||||||||
| 148 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.22 | 0.91 - 4.28 | GI/L | ||||||||||
| 149 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.32 | 0.12 - 0.92 | GI/L | ||||||||||
| 150 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.10 | 0 - 0.57 | GI/L | ||||||||||
| 151 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||||
| 152 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 63.9 | 40.5 - 75 | % | ||||||||||
| 153 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 26.5 | 15.4 - 48.5 | % | ||||||||||
| 154 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.9 | 2.6 - 10.1 | % | ||||||||||
| 155 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.2 | 0 - 6.8 | % | ||||||||||
| 156 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||||
| 157 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 207 | 140 - 400 | GI/L | ||||||||||
| 158 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 159 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | LIPID PANEL | Direct HDL-C 4th Generation | 1.70 | H | 1.03 - 1.53 | mmol/L | |||||||||
| 160 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | LIPID PANEL | Triglycerides (GPO) | 0.59 | 0.59 - 2.96 | mmol/L | ||||||||||
| 161 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | LIPID PANEL | Cholesterol (High Performance) | 4.49 | 4.42 - 7.53 | mmol/L | ||||||||||
| 162 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | LIPID PANEL | LDL Chol Friedewald 4th | 2.52 | 0 - 3.34 | mmol/L | ||||||||||
| 163 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | PA1 EEA-2? | Approved to use EEA-2? | No | ||||||||||||
| 164 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 05-May-2026 | |||||||||||
| 165 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 11:30 | |||||||||||
| 166 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 05-May-2026 | |||||||||||
| 167 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 12:45 | |||||||||||
| 168 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 05-May-2026 | |||||||||||
| 169 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 11:30 | |||||||||||
| 170 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 05-May-2026 | |||||||||||
| 171 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 06:30 | |||||||||||
| 172 | CZ100092001 | Female | Induction Week 0 | May 5, 2026 11:30 AM | 6227323334 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 173 | CZ100092002 | Female | TB Testing | May 5, 2026 9:00 AM | 6227323348 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 174 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 175 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 176 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 177 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 24-Apr-2026 | |||||||||||
| 178 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 11:09 | |||||||||||
| 179 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 180 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 181 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 182 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 12:00 | ||||||||||||
| 183 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 29-Apr-2026 | ||||||||||||
| 184 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 185 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 186 | CZ100092001 | Female | Biopsy | Apr 24, 2026 12:00 AM | 6227323351 | ULCERATED AREA | Is biopsy site ulcerated? | No | ||||||||||||
| 187 | CZ100092002 | Female | Stool Pathogens | Apr 20, 2026 6:10 AM | 6227323341 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 188 | CZ100092002 | Female | Stool Pathogens | Apr 20, 2026 6:10 AM | 6227323341 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 189 | CZ100092002 | Female | Stool Pathogens | Apr 20, 2026 6:10 AM | 6227323341 | OVA AND PARASITES 1 | Concentrate Exam | No ova or parasites found | ||||||||||||
| 190 | CZ100092002 | Female | Stool Pathogens | Apr 20, 2026 6:10 AM | 6227323341 | OVA AND PARASITES 1 | Smear for Microsporidia | No Microsporidia seen. | ||||||||||||
| 191 | CZ100092002 | Female | Stool Pathogens | Apr 20, 2026 6:10 AM | 6227323341 | OVA AND PARASITES 1 | Modified acid-fast stain | No coccidian parasites seen | ||||||||||||
| 192 | CZ100092002 | Female | Stool Pathogens | Apr 20, 2026 6:10 AM | 6227323341 | OVA AND PARASITES 2 | Trichrome Smear | No ova or parasites found | ||||||||||||
| 193 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||||
| 194 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.3 | 0 - 6.2 | umol/L | ||||||||||
| 195 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Alkaline Phosphatase | 56 | 35 - 104 | U/L | ||||||||||
| 196 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | ALT (SGPT) | 11 | 4 - 43 | U/L | ||||||||||
| 197 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | AST (SGOT) | 25 | 8 - 40 | U/L | ||||||||||
| 198 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | GGT | 10 | 4 - 49 | U/L | ||||||||||
| 199 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | LDH | 159 | 53 - 234 | U/L | ||||||||||
| 200 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Urea Nitrogen | 6.1 | 1.4 - 8.6 | mmol/L | ||||||||||
| 201 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 90 | 31 - 101 | umol/L | ||||||||||
| 202 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Serum Glucose | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||||
| 203 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Serum Uric Acid | 268 | 149 - 446 | umol/L | ||||||||||
| 204 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Calcium (EDTA) | 2.43 | 2.07 - 2.64 | mmol/L | ||||||||||
| 205 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Phosphorus | 1.14 | 0.71 - 1.65 | mmol/L | ||||||||||
| 206 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Total Protein | 70 | 61 - 84 | g/L | ||||||||||
| 207 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||||
| 208 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Creatine Kinase | 176 | 26 - 192 | U/L | ||||||||||
| 209 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 210 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Serum Potassium | 4.6 | 3.5 - 5.2 | mmol/L | ||||||||||
| 211 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Serum Bicarbonate | 27.2 | 19.3 - 29.3 | mmol/L | ||||||||||
| 212 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||||
| 213 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CHEMISTRY PANEL | Magnesium | 0.93 | 0.66 - 1.07 | mmol/L | ||||||||||
| 214 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 65 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 215 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||||
| 216 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 217 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 138 | 116 - 164 | g/L | ||||||||||
| 218 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.34 - 0.48 | |||||||||||
| 219 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | 4.1 - 5.6 | TI/L | ||||||||||
| 220 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 32 | 26 - 34 | pg | ||||||||||
| 221 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 222 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 98 | fL | ||||||||||
| 223 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.05 | 3.8 - 10.7 | GI/L | ||||||||||
| 224 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 1.87 | L | 1.96 - 7.23 | GI/L | |||||||||
| 225 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.72 | 0.91 - 4.28 | GI/L | ||||||||||
| 226 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.29 | 0.12 - 0.92 | GI/L | ||||||||||
| 227 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||||
| 228 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||||
| 229 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 46.1 | 40.5 - 75 | % | ||||||||||
| 230 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 42.6 | 15.4 - 48.5 | % | ||||||||||
| 231 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.2 | 2.6 - 10.1 | % | ||||||||||
| 232 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.4 | 0 - 6.8 | % | ||||||||||
| 233 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||||
| 234 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 216 | 140 - 400 | GI/L | ||||||||||
| 235 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 236 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 237 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 238 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 239 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 240 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 241 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 242 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 243 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Positive | RX | Result verified by repeat analysis | Normal=Negative | |||||||||
| 244 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||||
| 245 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | SERUM BETA HCG | B-hCG, Quantitative | 0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||||
| 246 | CZ100092002 | Female | Screening | Apr 16, 2026 12:00 PM | 6227323332 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 247 | CZ100092001 | Female | Stool Pathogens | Apr 2, 2026 6:15 AM | 6227323340 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 248 | CZ100092001 | Female | Stool Pathogens | Apr 2, 2026 6:15 AM | 6227323340 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 249 | CZ100092001 | Female | Stool Pathogens | Apr 2, 2026 6:15 AM | 6227323340 | OVA AND PARASITES 1 | Concentrate Exam | No ova or parasites found | ||||||||||||
| 250 | CZ100092001 | Female | Stool Pathogens | Apr 2, 2026 6:15 AM | 6227323340 | OVA AND PARASITES 1 | Smear for Microsporidia | No Microsporidia seen. | ||||||||||||
| 251 | CZ100092001 | Female | Stool Pathogens | Apr 2, 2026 6:15 AM | 6227323340 | OVA AND PARASITES 1 | Modified acid-fast stain | No coccidian parasites seen | ||||||||||||
| 252 | CZ100092001 | Female | Stool Pathogens | Apr 2, 2026 6:15 AM | 6227323340 | OVA AND PARASITES 2 | Trichrome Smear | No ova or parasites found | ||||||||||||
| 253 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||||
| 254 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.4 | 0 - 6.2 | umol/L | ||||||||||
| 255 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Alkaline Phosphatase | 56 | 35 - 104 | U/L | ||||||||||
| 256 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | ALT (SGPT) | 15 | 4 - 43 | U/L | ||||||||||
| 257 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||||
| 258 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | GGT | 12 | 4 - 49 | U/L | ||||||||||
| 259 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | LDH | 137 | 53 - 234 | U/L | ||||||||||
| 260 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Urea Nitrogen | 2.7 | 1.4 - 8.6 | mmol/L | ||||||||||
| 261 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 58 | 31 - 101 | umol/L | ||||||||||
| 262 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Serum Glucose | 5.2 | 3.9 - 5.6 | mmol/L | ||||||||||
| 263 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Serum Uric Acid | 207 | 125 - 428 | umol/L | ||||||||||
| 264 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Calcium (EDTA) | 2.43 | 2.07 - 2.64 | mmol/L | ||||||||||
| 265 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Phosphorus | 1.15 | 0.71 - 1.65 | mmol/L | ||||||||||
| 266 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Total Protein | 67 | 61 - 84 | g/L | ||||||||||
| 267 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||||
| 268 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Creatine Kinase | 81 | 26 - 192 | U/L | ||||||||||
| 269 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||||
| 270 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||||
| 271 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Serum Bicarbonate | 23.7 | 19.3 - 29.3 | mmol/L | ||||||||||
| 272 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||||
| 273 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CHEMISTRY PANEL | Magnesium | 0.91 | 0.66 - 1.07 | mmol/L | ||||||||||
| 274 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 107 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 275 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||||
| 276 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 277 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 147 | 116 - 164 | g/L | ||||||||||
| 278 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.34 - 0.48 | |||||||||||
| 279 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.1 - 5.6 | TI/L | ||||||||||
| 280 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 281 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 282 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 98 | fL | ||||||||||
| 283 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.74 | 3.8 - 10.7 | GI/L | ||||||||||
| 284 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.76 | 1.96 - 7.23 | GI/L | ||||||||||
| 285 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.18 | 0.91 - 4.28 | GI/L | ||||||||||
| 286 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.46 | 0.12 - 0.92 | GI/L | ||||||||||
| 287 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.26 | 0 - 0.57 | GI/L | ||||||||||
| 288 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.09 | 0 - 0.2 | GI/L | ||||||||||
| 289 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 65.5 | 40.5 - 75 | % | ||||||||||
| 290 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 20.6 | 15.4 - 48.5 | % | ||||||||||
| 291 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.9 | 2.6 - 10.1 | % | ||||||||||
| 292 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.5 | 0 - 6.8 | % | ||||||||||
| 293 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.5 | 0 - 2 | % | ||||||||||
| 294 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 263 | 140 - 400 | GI/L | ||||||||||
| 295 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 296 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 297 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 298 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 299 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 300 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 301 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 302 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | PA1 EEA-2? | Approved to use EEA-2? | No | ||||||||||||
| 303 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 304 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||||
| 305 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||||
| 306 | CZ100092001 | Female | Screening | Mar 31, 2026 8:30 AM | 6227323330 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm |